Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900022322Phase 4Recruiting
Phase 4, randomised, open-label trial of norepinephrine in hypotension (4 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoints: Blood pressure, ED50 of norepinephrine infusion and 1 more. Started Apr 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900022322.